Sodium Chloride 0.9% Injection shortage
Not a nationwide shortage — Hospira has told the FDA it is discontinuing its sodium chloride 0.9% injections.
- The FDA lists this under “To be discontinued” as of Nov 22, 2026: a company stopping its own product.
- 12 other companies sell the same medicine and have not reported a problem, so your pharmacy may be able to order another company’s version.
- Status
- FDA term: “To Be Discontinued”
- Products on the record
- 3
- Category
- First posted
- Dec 3, 2025
- Last updated
- Dec 3, 2025
- Medicaid use (2026)
This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD Compiled from public FDA (openFDA) and CMS (Medicaid) data sources. Editorial policy
The Bottom Line
Hospira is stopping its Sodium Chloride 0.9% Injection in ADD-Vantage flexible containers, and the change may be permanent. The same medicine is still listed by other makers that have not reported a shortage, but Hospira's 50 mL, 100 mL, and 250 mL ADD-Vantage sizes have no listed source right now.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Is Sodium Chloride 0.9% Being Discontinued? Status as of Nov 22, 2026
Not as a whole, as of Nov 22, 2026. Hospira is stopping its own version only; 12 other companies still sell the same medicine and have not reported a problem. Your pharmacy may need to order another company’s version.
The charts count only the companies that reported this shortage to the FDA; companies that haven’t reported a problem are listed after them, and the Supply-Risk rating counts them too.
Availability of the Affected Products
From the FDA shortage report: 3 products
Is Every Size Still Made?
A medicine often comes in several sizes, and more than one company may make each. This shows whether at least one company still makes each size on the record: a company on the shortage report that still has supply, or another company that sells it.
0 of 3 sizes
- 50 mL ADD-Vantage® Flexible ContainerNo company found making it
- 100 mL ADD-Vantage® Flexible ContainerNo company found making it
- 250 mL ADD-Vantage® Flexible ContainerNo company found making it
Other Companies Listing the Same Medicine, Not Reporting a Shortage
Companies that list Sodium Chloride 0.9% Injection with the FDA and have not reported a shortage (not counted in the charts above).
- B. Braun Medical Inc.
- Baxter Healthcare Corporation
- Nephron Pharmaceuticals Corporation
- ICU Medical Inc.
- Becton Dickinson and Company
- Fresenius Medical Care de Mexico, S.A. de C.V.
- Fresenius Medical Care Renal Therapies Group, LLC
- HF Acquisition Co LLC, DBA HealthFirst
- Fresenius Kabi USA, LLC
- SOLA Pharmaceuticals, LLC
- LABORATORIOS GRIFOLS SA
- Nextgen Pharmaceuticals LLC
Shortage Timeline
- Dec 3, 2025 Discontinuation notice on file 3 of 3 products affected.
- Dec 3, 2025 First reported to the FDA 3 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
Which Sodium Chloride 0.9% Products Are Affected, by Company
Only the companies that told the FDA about a supply problem are listed here, so other companies may still have stock (see Where else can I get sodium chloride 0.9%?).
Company: Hospira, Inc., a Pfizer Company
-
Sodium Chloride 0.9% Injection, 50 mL ADD-Vantage® Flexible Container
- Size
- 50 mL ADD-Vantage® Flexible Container
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
-
Sodium Chloride 0.9% Injection, 250 mL ADD-Vantage® Flexible Container
- Size
- 250 mL ADD-Vantage® Flexible Container
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
-
Sodium Chloride 0.9% Injection, 100 mL ADD-Vantage® Flexible Container
- Size
- 100 mL ADD-Vantage® Flexible Container
- Availability
- Not stated
Notes: Discontinuation of the manufacture of the drug
Why Is Hospira Discontinuing Sodium Chloride 0.9%?
A note from Dr. Brian Staiger, PharmD · Written Nov 19, 2026
I wanted to explain what's going on with this one. The FDA lists Sodium Chloride 0.9% Injection as "To Be Discontinued," but it didn't give a specific reason code, and the manufacturer didn't share a public reason beyond saying it is stopping production of these products.
The report comes from Hospira, a Pfizer company. It covers three Sodium Chloride 0.9% Injection packages, all in ADD-Vantage® Flexible Containers:
- 50 mL (NDC 0409-7101-66)
- 100 mL (NDC 0409-7101-67)
- 250 mL (NDC 0409-7101-02)
For each one, Hospira's note says "Discontinuation of the manufacture of the drug." In plain words, that means Hospira is stopping production of these particular packages. The report doesn't give any dates, and it doesn't mention any strength or package size that Hospira will keep making. It also only speaks for Hospira's products, so it doesn't tell us anything about other companies that may make sodium chloride.
What Should I Do If I Take Sodium Chloride 0.9%?
A note from Dr. Brian Staiger, PharmD · Written Nov 19, 2026
Sodium Chloride 0.9% Injection (sterile saline) in the ADD-Vantage® Flexible Container is currently on the FDA drug-shortage list. The overall supply risk is rated low, and this report comes from one manufacturer, Hospira, Inc., a Pfizer Company.
All three listed sizes currently have no available source from the reporting company: the 50 mL, 100 mL, and 250 mL ADD-Vantage® Flexible Containers. The reason given for each is that the manufacturer is discontinuing the product. Because it is marked "to be discontinued," this supply problem with these specific containers may be permanent. However, saline itself is still made by other companies.
What you can do:
- Do not stop, skip, or change your treatment on your own.
- Ask your pharmacy or care team about sourcing the same medicine from another maker. Our records show sodium chloride 0.9% injection from companies such as B. Braun Medical, Baxter Healthcare, ICU Medical, Nephron Pharmaceuticals, and Becton Dickinson. These may come in different container types and may not be in local stock.
- Talk with your prescriber or pharmacist about the best option for you. Another product may not be right for every person or every use.
- The manufacturer's contact number is listed on this page for reference. Pharmacies usually handle these calls.
This is general information based on national, manufacturer-reported FDA data. It may not match your local pharmacy's stock, and it is not individualized medical advice.
Quick checklist for the pharmacy counter
- Ask your pharmacy to check other companies’ versions, other sizes, package sizes, and nearby stores — the options below are a starting point.
- If this is part of an ongoing or essential regimen (for example HIV, seizure, heart, transplant, diabetes or mental-health medicines), arrange continued supply before you run out rather than rationing doses.
Where Else Can I Get Sodium Chloride 0.9%?
From the current FDA NDC Directory: the same medicine from companies that have not reported a shortage.
- Some listings are repackagers, which relabel another company’s product.
- A listing is not stock: these may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same Medicine From Other Companies (Not Reporting a Shortage)
The same active ingredient, dosage form and route, from companies that have not reported a shortage to the FDA.
| Product | Strength | Form / route | Company | NDC |
|---|---|---|---|---|
| Sodium Chloride | 9 mg/mL | Injection, Solution · Intravenous | B. Braun Medical Inc. | 00264-1800-31 |
| Sodium Chloride | 0.9 g/100 mL | Injection, Solution · Intravenous | B. Braun Medical Inc. | 00264-5802-00 |
| Sodium Chloride | 9 mg/mL | Injection · Intravenous | B. Braun Medical Inc. | 00264-9375-88 |
| Sodium Chloride | 9 g/1000 mL | Injection, Solution · Intravenous | Baxter Healthcare Corporation | 00338-0049-01 |
| Sodium Chloride | 900 mg/100 mL | Injection · Intravenous | Baxter Healthcare Corporation | 00338-0553-11 |
| Sodium Chloride | 450 mg/50 mL | Injection · Intravenous | Baxter Healthcare Corporation | 00338-9151-30 |
| Sodium Chloride | 9 mg/mL | Injection · Intravenous | Nephron Pharmaceuticals Corporation | 00487-4301-05 |
| Sodium Chloride | 900 mg/100 mL | Injection, Solution · Intravenous | ICU Medical Inc. | 00990-7983-02 |
| Sodium Chloride | 9 mg/mL | Injection, Solution · Intravenous | Becton Dickinson and Company | 17271-0701-02 |
| Sodium Chloride | 900 mg/100 mL | Injection · Intravenous | Fresenius Medical Care de Mexico, S.A. de C.V. | 46163-0300-10 |
| Sodium Chloride | 900 mg/100 mL | Injection · Intravenous | Fresenius Medical Care Renal Therapies Group, LLC | 49230-0300-10 |
| 0.9% Sodium Chloride | 9 g/1000 mL | Injection, Solution · Intravenous | HF Acquisition Co LLC, DBA HealthFirst | 51662-1609-01 |
| Sodium Chloride | 9 mg/mL | Injection, Solution · Intravenous | Fresenius Kabi USA, LLC | 63323-0623-53 |
| Sodium Chloride | 9 g/1000 mL | Injection, Solution · Intravenous | SOLA Pharmaceuticals, LLC | 70512-0841-06 |
| Sodium Chloride | 9 g/1000 mL | Injection, Solution · Intravenous | LABORATORIOS GRIFOLS SA | 76297-0001-01 |
| Sodium Chloride | 9 g/1000 mL | Injection, Solution · Intravenous | Nextgen Pharmaceuticals LLC | 79672-0613-10 |
Therapeutic Equivalents and Pricing 15 products
Other products the FDA rates as interchangeable with the affected sizes, with what pharmacies pay for each and whether pharmacies are still buying it. Cheapest first.
| Product | Manufacturer | Package | Pharmacy cost per unit (NADAC) | FDA rated equivalent | Availability |
|---|---|---|---|---|---|
| Sodium Chloride 900 mg/100mLNDC 00409-7101-02 | Hospira, | 24 pouches | $0.021 | AP | Discontinued |
| Sodium Chloride 900 mg/100mLNDC 51662-1522-01 | HF | 500 ml | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00338-0186-04 | Baxter | 100 ml | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00338-0162-01 | Baxter | 100 ml | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00990-7984-13 | ICU | 48 pouches | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00338-0196-04 | Baxter | 100 ml | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00338-9159-30 | Baxter | 100 ml | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00338-0166-01 | Baxter | 100 ml | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00338-9662-35 | Baxter | 100 ml | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00338-0553-11 | Baxter | 50 ml | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 46163-0300-10 | Fresenius | 1000 ml | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00409-7101-66 | Hospira, | 10 pouches | — | AP | Discontinued |
| Sodium Chloride 900 mg/100mLNDC 49230-0300-10 | Fresenius | 1000 ml | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00990-7983-02 | ICU | 24 pouches | — | AP | FDA listed |
| Sodium Chloride 900 mg/100mLNDC 00409-7101-67 | Hospira, | 10 pouches | — | AP | FDA listed |
These have the same ingredient, strength, form and route, and the FDA rates them as substitutes (an “AB” rating in its Orange Book). The price is what pharmacies pay on average (CMS’s NADAC survey), not what you pay. Availability comes from recent pharmacy prices, not a stock check.
Other Drugs in the Same Treatment Class
These are different medicines — not other versions of sodium chloride 0.9% — that fall in the same broad treatment class (sodium/saline preparations). They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Codes & Classification for pharmacists and billers
- GCN Seq No
- 059910
- GCN
- 25839
- HICL code
- 008255
- Ingredient (HICL)
- 0.9 % Sodium Chloride
- HIC1 code
- C
- Therapeutic class — broad (HIC1)
- Electrolyte Balance/Metabolism/Nutrition
- HIC2 code
- C1
- Therapeutic class — intermediate (HIC2)
- Drugs Affecting Electrolyte Balance
- HIC3 code
- C1B
- Therapeutic class — specific (HIC3)
- Sodium/Saline Preparations
- AHFS code
- 40:12.00.00
- AHFS class
- Replacement Preparations
- FDB label name
- SODIUM CHLORIDE 0.9% SOLN
- FDB brand name
- Sodium Chloride
- Legend status
- F — Federal legend — prescription drug or device
- GPI-14
- 79750010002021
- GPI class
- Sodium Chloride
Where does this data come from? Identity codes come from First Databank (FDB) (HICL ingredient, HIC1–3 therapeutic-class hierarchy, GCN, AHFS class, legend status) and Medi-Span GPI, mapped from a representative affected NDC. Licensed reference data — for identification only.
Sodium chloride 0.9% Shortage FAQs
Is sodium chloride 0.9% discontinued?
Only Hospira’s version. Hospira has told the FDA it is stopping its own product (listed under “To be discontinued” as of Nov 22, 2026), while 12 other companies still sell the same medicine and have not reported a problem (B. Braun Medical, Baxter Healthcare, Nephron Pharmaceuticals and 9 more). It is not a nationwide shortage.
Which sizes of sodium chloride 0.9% are affected?
The FDA record covers 3 sizes: 50 mL ADD-Vantage® Flexible Container, 100 mL ADD-Vantage® Flexible Container, 250 mL ADD-Vantage® Flexible Container. Right now we could not find any company still making any of them: the companies that reported the shortage say they are out, and no other company we found sells them. Ask your pharmacist and prescriber about options before you run out.
Which sodium chloride 0.9% products are affected?
Sodium Chloride 0.9% Injection, 50 mL ADD-Vantage® Flexible Container (NDC 00409-7101-66); Sodium Chloride 0.9% Injection, 250 mL ADD-Vantage® Flexible Container (NDC 00409-7101-02); Sodium Chloride 0.9% Injection, 100 mL ADD-Vantage® Flexible Container (NDC 00409-7101-67). The full per-NDC list (availability, company and status) is in the table above — each NDC links to its own page.
When will sodium chloride 0.9% be available again?
A discontinuation is usually permanent for that company’s product. The same medicine is still sold by B. Braun Medical, Baxter Healthcare, Nephron Pharmaceuticals and 9 more, so ask your pharmacy to order another company’s version.
Can I still get sodium chloride 0.9% somewhere?
Other companies (B. Braun Medical, Baxter Healthcare, Nephron Pharmaceuticals and 9 more) sell the same medicine and have not reported a problem. See “Where else can I get sodium chloride 0.9%?” above — stock still varies by pharmacy.
What should I do if I take sodium chloride 0.9%?
Don’t stop or change it on your own. Ask your pharmacist whether they can order it from another company or a different size or package size, and ask your prescriber about a long-term plan before your supply runs out.
How to Read the Supply-Risk Rating
Each drug in shortage gets one point for each of five risk factors that apply to it (listed with its rating). It is our estimate across the country, not a check of your pharmacy’s shelves.
- Low0 to 2 risk factors Your pharmacy can often still get it, though it may need to be ordered.Sodium chloride 0.9% is rated Low: 1 of 5 risk factors.
- Medium3 risk factors Supply is tight in several ways. Finding it may take some calling around.
- High4 or 5 risk factors, or no company found making it Few companies are left making it, or some strengths have no maker at all. It may be hard to find for a while.
Back to this drug’s rating ↑ · How we rate supply risk, in full
Where This Data Comes From
- The FDA’s drug shortage database, checked every day: the companies, their products and the codes on their boxes (NDCs), the status, the reason and the dates. See the FDA’s record for this shortage ↗
- The FDA’s NDC Directory: the other companies that make the same medicine, which the supply-risk rating counts.
- CMS Medicaid prescription data: how widely it is used. It counts Medicaid prescriptions only, so it is a rough guide, not total U.S. use.
- First Databank and CMS NADAC: matching the same medicine across companies, and what pharmacies pay for the equivalents.
For reference only. Check with your pharmacist, the drug’s maker or the FDA before acting on it.